StockData
Aethlon Medical Inc logo

Aethlon Medical Inc (AEMD) stock

AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)

Close on Nov 18, 2026Market cap $3.63MP/E –Yield –

Aethlon Medical cash

Cash and short-term investments held at the end of each period.

Aethlon Medical's cash was $4.93M at Jun 30, 2026. For fiscal 2026 it was $5.03M, down 10.2% from the year before. Over ten years it grew 9.0% a year on average. The highest annual figure on record is $17.16M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2026Mar 31, 2026$5.03M-10.2%
FY2025Mar 31, 2025$5.60M+1.3%
FY2024Mar 31, 2024$5.53M+2111.8%
FY2023Mar 31, 2023$250.00K-98.5%
FY2022Mar 31, 2022$17.16M+73.2%
FY2021Mar 31, 2021$9.91M+3.2%
FY2020Mar 31, 2020$9.60M+150.9%
FY2019Mar 31, 2019$3.83M-45.1%
FY2018Mar 31, 2018$6.97M+347.1%
FY2017Mar 31, 2017$1.56M-26.6%
FY2016Mar 31, 2016$2.12M+148.2%
FY2015Mar 31, 2015$855.60K-31.6%
FY2014Mar 31, 2014$1.25M+898.0%
FY2013Mar 31, 2013$125.27K-12.9%
FY2012Mar 31, 2012$143.91K+816.4%
FY2011Mar 31, 2011$15.70K-76.9%
FY2010Mar 31, 2010$67.95K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$4.93M-11.9%
Q4 FY2026CQ1 2026Mar 31, 2026$5.03M+4.2%
Q3 FY2026CQ4 2025Dec 31, 2025$6.96M+1.4%
Q1 FY2026CQ2 2025Jun 30, 2025$3.77M-58.5%
Q4 FY2025CQ1 2025Mar 31, 2025$5.60M+1.3%
Q3 FY2025CQ4 2024Dec 31, 2024$4.83M-39.5%
Q2 FY2025CQ3 2024Sep 30, 2024$6.86M-32.6%
Q1 FY2025CQ2 2024Jun 30, 2024$9.07M-29.7%
Q4 FY2024CQ1 2024Mar 31, 2024$5.53M+2111.8%
Q3 FY2024CQ4 2023Dec 31, 2023$7.97M-54.4%
Q2 FY2024CQ3 2023Sep 30, 2023$10.18M-48.1%
Q1 FY2024CQ2 2023Jun 30, 2023$12.90M-13.6%
Q4 FY2023CQ1 2023Mar 31, 2023$250.00K-98.5%
Q3 FY2023CQ4 2022Dec 31, 2022$17.50M-14.2%
Q2 FY2023CQ3 2022Sep 30, 2022$19.60M-15.6%
Q1 FY2023CQ2 2022Jun 30, 2022$14.92M-40.7%
Q4 FY2022CQ1 2022Mar 31, 2022$17.16M+73.2%
Q3 FY2022CQ4 2021Dec 31, 2021$20.39M+68.1%
Q2 FY2022CQ3 2021Sep 30, 2021$23.22M+60.5%
Q1 FY2022CQ2 2021Jun 30, 2021$25.17M+60.1%
Q4 FY2021CQ1 2021Mar 31, 2021$9.91M+3.2%
Q3 FY2021CQ4 2020Dec 31, 2020$12.13M+198.9%
Q2 FY2021CQ3 2020Sep 30, 2020$14.47M+1742.2%
Q1 FY2021CQ2 2020Jun 30, 2020$15.72M+530.8%
Q4 FY2020CQ1 2020Mar 31, 2020$9.60M+150.9%
Q3 FY2020CQ4 2019Dec 31, 2019$4.06M-15.9%
Q2 FY2020CQ3 2019Sep 30, 2019$785.66K-84.5%
Q1 FY2020CQ2 2019Jun 30, 2019$2.49M-59.3%
Q4 FY2019CQ1 2019Mar 31, 2019$3.83M-45.1%
Q3 FY2019CQ4 2018Dec 31, 2018$4.82M-14.0%
Q2 FY2019CQ3 2018Sep 30, 2018$5.08M+452.0%
Q1 FY2019CQ2 2018Jun 30, 2018$6.12M+1771.3%
Q4 FY2018CQ1 2018Mar 31, 2018$6.97M+347.1%
Q3 FY2018CQ4 2017Dec 31, 2017$5.61M+792.6%
Q2 FY2018CQ3 2017Sep 30, 2017$920.07K+65.4%
Q1 FY2018CQ2 2017Jun 30, 2017$327.21K-74.7%
Q4 FY2017CQ1 2017Mar 31, 2017$1.56M–
Q3 FY2017CQ4 2016Dec 31, 2016$628.62K–
Q2 FY2017CQ3 2016Sep 30, 2016$556.35K–
Q1 FY2017CQ2 2016Jun 30, 2016$1.29M–

More Aethlon Medical figures

See a number that looks wrong?